Jason O'Byrne
EVP & Chief Financial Officer · 3 filings · Latest: Mar 20, 2026
Vir Biotechnology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VIR | Jason O'Byrne | EVP & Chief Financial Officer | Feb 24, 2026 | Sale | $9.53 | 1,634 | $15.6K | 162,615 | |
VIR | Jason O'Byrne | EVP & Chief Financial Officer | Feb 23, 2026 | Sale | $7.45 | 2,089 | $15.6K | 164,249 | |
VIR | O'Byrne Jason | — | Feb 24, 2026 | Proposed Sale | $9.53 | 1,634 | $15.6K | — | |
VIR | O'Byrne Jason | — | Feb 23, 2026 | Proposed Sale | $7.45 | 2,089 | $15.6K | — | |
VIR | O'Byrne Jason | — | Nov 17, 2025 | Proposed Sale | $5.56 | 6,799 | $37.8K | — |